← Back to Search

Behavioral Intervention

Community B for Domestic Violence

N/A
Waitlist Available
Led By Terri Sullivan, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 14 through 24
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 17 weeks after baseline
Awards & highlights

Study Summary

This trial aims to reduce youth violence by using a hospital-based and universal prevention strategy that focuses on increasing community capacity for prevention.

Who is the study for?
This trial is for communities affected by youth violence, focusing on adolescents who have experienced domestic violence or other violent events. It aims to involve young people and community stakeholders in developing prevention strategies.Check my eligibility
What is being tested?
The study tests 'Healthy Communities for Youth', a program combining the Emerging Leaders hospital-based intervention with universal strategies like participatory action research (PAR) to promote positive development and reduce youth violence.See study design
What are the potential side effects?
Since this trial involves community programs rather than medical treatments, there are no traditional side effects. However, unintended consequences may include changes in community dynamics or resistance to new interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 14 and 24 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 17 weeks after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 17 weeks after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Beliefs About Aggression and Alternatives (BAA)
Civic Engagement
Critical Consciousness
+8 more
Secondary outcome measures
Adverse Childhood Experiences (ACES)
Behavior Assessment System for Children (BASC)
Developmental Assets Profile (DAP)
+7 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Community BExperimental Treatment3 Interventions
Group II: Community AExperimental Treatment3 Interventions
Group III: Community CActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,473,847 Total Patients Enrolled
Virginia Commonwealth UniversityLead Sponsor
700 Previous Clinical Trials
22,883,655 Total Patients Enrolled
Terri Sullivan, PhDPrincipal InvestigatorVirginia Commonwealth University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings left for volunteers to participate in this research?

"Information posted on clinicaltrials.gov declares that this trial is no longer recruiting patients, as it was last updated in December of 2023. However, 75 other medical studies are currently offering enrolment opportunities to participants."

Answered by AI

What are the chief goals of this clinical analysis?

"This experiment will evaluate the efficacy of a Gun Violence Questionnaire (GVQ) over two separate points in time, Baseline and 17 weeks later. Secondary measurements include Developmental Assets Profile (DAP), Behavior Assessment System for Children (BASC), and Orientation Toward Leadership to assess qualities that may promote resilience among youth aged 11-18."

Answered by AI
~1483 spots leftby Mar 2026